EGFR and non-small cell lung carcinoma: As the outcomes of immunotherapy when combined with chemotherapy can be improved, we investigated the efficacy of nivolumab therapy following platinum‐based chemotherapy in EGFR‐mutant NSCLC which progressed after EGFR‐TKI.